Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
10.58
-0.23 (-2.13%)
Sep 10, 2026, 4:00 PM EDT - Market closed
Vir Biotechnology Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -251.68 | -437.99 | -521.96 | -615.06 | 515.84 | 528.58 |
Depreciation & Amortization | 11.51 | 11.68 | 14.56 | 19.45 | 6.78 | 5.81 |
Asset Writedown & Restructuring Costs | 0.26 | 0.65 | 38.72 | 17.32 | - | - |
Loss (Gain) From Sale of Investments | 6.74 | 7.75 | 10.93 | 13.18 | 102.2 | -138.29 |
Stock-Based Compensation | 47.04 | 49.07 | 78.46 | 111.32 | 102.08 | 83.78 |
Other Operating Activities | 6.29 | -0.5 | 16.27 | 7.72 | 270.99 | 100.92 |
Change in Accounts Receivable | - | - | - | - | 770.04 | -773.08 |
Change in Accounts Payable | 5.64 | 5 | -0.99 | 0.73 | 0.8 | -0.17 |
Change in Unearned Revenue | - | - | - | - | -33.3 | 92.04 |
Change in Other Net Operating Assets | -28.3 | -27.44 | -82.33 | -333.44 | -72.17 | 52.82 |
Operating Cash Flow | -202.51 | -391.78 | -446.35 | -778.79 | 1,663 | -47.59 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -1.09 | -4.83 | -7.3 | -21.57 | -68.01 | -21.82 |
Sale of Property, Plant & Equipment | -0.07 | 0.25 | 3.37 | - | - | - |
Investment in Securities | -57.05 | 314.95 | 503.3 | 186.2 | -1,125 | -119 |
Investing Cash Flow | -58.21 | 310.37 | 499.37 | 164.63 | -1,193 | -140.81 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | - | - | - | - | -0.26 |
Net Debt Issued (Repaid) | - | - | - | - | - | -0.26 |
Issuance of Common Stock | 242.04 | 4.15 | 4.55 | 7.77 | 36.22 | 100.59 |
Other Financing Activities | -0 | -0.36 | -0.17 | -0.29 | -1.46 | - |
Financing Cash Flow | 242.04 | 3.79 | 4.39 | 7.48 | 34.76 | 100.33 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -18.68 | -77.63 | 57.4 | -606.68 | 504.55 | -88.07 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -203.59 | -396.61 | -453.65 | -800.36 | 1,595 | -69.41 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -67.14% | -578.52% | -611.35% | -928.71% | 98.73% | -6.34% |
Free Cash Flow Per Share | -1.37 | -2.86 | -3.33 | -5.97 | 11.83 | -0.52 |
Levered Free Cash Flow | -38.89 | -174.44 | -372.22 | -597.12 | 1,469 | -246.55 |
Unlevered Free Cash Flow | -38.89 | -174.44 | -372.22 | -597.12 | 1,469 | -246.55 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Income Tax Paid | 2.42 | 2.42 | - | - | 252.03 | - |
Change in Working Capital | -22.66 | -22.45 | -83.32 | -332.71 | 665.37 | -628.39 |